| Adriana Guigova, DO | |
|
49 Nesconset Hwy, Port Jefferson Station, NY 11776-2628 | |
| (631) 751-0000 | |
| (631) 509-6559 |
| Full Name | Adriana Guigova |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 49 Nesconset Hwy, Port Jefferson Station, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891094447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 266928 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Shepherd Hospice | Farmingdale, NY | Hospice |
| St Catherine Of Siena Hospital | Smithtown, NY | Hospital |
| John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| St Charles Hospital | Port jefferson, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore Hematology Oncology Associates Pc | 1456243641 | 314 |
News Archive
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
About 100 low- and middle-income countries could receive donated shipments of the H1N1 (swine flu) vaccine as early as November, Marie-Paule Kieny, of the WHO, told journalists Monday, Agence France-Presse reports. "Dozens of millions of doses are being lined up following offers from pharmaceutical companies," including Sanofi-Aventis, GlaxoSmithKline and MedImmune, as well as a coalition of developed nations "that have pledged to release 10 percent of their vaccine purchases for poor nations," the news service writes (10/12).
Shielding vulnerable people has been central to the response to COVID-19, but how well does it work? A Swansea University research project has received funding to examine the evidence, to see what lessons can be learned for the future.
Results of the first study of its kind to link abnormalities in circadian rhythms to changes in specific neurotransmitters in people with bipolar disorder will be published this week in the journal Biological Psychiatry.
› Verified 1 days ago
| Entity Name | North Shore Hematology Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396794574 PECOS PAC ID: 1456243641 Enrollment ID: O20040324001766 |
News Archive
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
About 100 low- and middle-income countries could receive donated shipments of the H1N1 (swine flu) vaccine as early as November, Marie-Paule Kieny, of the WHO, told journalists Monday, Agence France-Presse reports. "Dozens of millions of doses are being lined up following offers from pharmaceutical companies," including Sanofi-Aventis, GlaxoSmithKline and MedImmune, as well as a coalition of developed nations "that have pledged to release 10 percent of their vaccine purchases for poor nations," the news service writes (10/12).
Shielding vulnerable people has been central to the response to COVID-19, but how well does it work? A Swansea University research project has received funding to examine the evidence, to see what lessons can be learned for the future.
Results of the first study of its kind to link abnormalities in circadian rhythms to changes in specific neurotransmitters in people with bipolar disorder will be published this week in the journal Biological Psychiatry.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adriana Guigova, DO 1500 Route 112 Bldg 4, Port Jefferson Station, NY 11776-8055 Ph: (631) 751-0000 | Adriana Guigova, DO 49 Nesconset Hwy, Port Jefferson Station, NY 11776-2628 Ph: (631) 751-0000 |
News Archive
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
About 100 low- and middle-income countries could receive donated shipments of the H1N1 (swine flu) vaccine as early as November, Marie-Paule Kieny, of the WHO, told journalists Monday, Agence France-Presse reports. "Dozens of millions of doses are being lined up following offers from pharmaceutical companies," including Sanofi-Aventis, GlaxoSmithKline and MedImmune, as well as a coalition of developed nations "that have pledged to release 10 percent of their vaccine purchases for poor nations," the news service writes (10/12).
Shielding vulnerable people has been central to the response to COVID-19, but how well does it work? A Swansea University research project has received funding to examine the evidence, to see what lessons can be learned for the future.
Results of the first study of its kind to link abnormalities in circadian rhythms to changes in specific neurotransmitters in people with bipolar disorder will be published this week in the journal Biological Psychiatry.
› Verified 1 days ago
Dr. Michael W Mendelson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5360 Nesconset Hghy, Suite B, Port Jefferson Station, NY 11776 Phone: 631-331-3200 Fax: 631-331-3694 | |
Matias M Dcosta, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 931 Hallock Ave, Port Jefferson Station, NY 11776 Phone: 631-331-7200 Fax: 631-331-8636 | |
Dr. Iryna Ilyasova, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112 Ste A, Port Jefferson Station, NY 11776 Phone: 631-686-1414 | |
Kinjal Amit Gosalia, STUDENT Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5316 Nesconset Hwy, Port Jefferson Station, NY 11776 Phone: 631-758-7003 Fax: 631-751-0506 | |
Zarlasht Khan, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112, Port Jefferson Station, NY 11776 Phone: 631-743-6840 | |
Anil Sangwan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 116 Terryville Rd, Port Jefferson Station, NY 11776 Phone: 631-928-2002 Fax: 631-473-4427 | |
Anish Desai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112 Ste B, Port Jefferson Station, NY 11776 Phone: 631-978-7633 Fax: 631-621-4119 |